Literature DB >> 29526388

Managing challenging interactions with family caregivers in the cancer setting: Guidelines for clinicians (TRIO Guidelines-2).

Rebekah Laidsaar-Powell1, Phyllis Butow2, Frances Boyle3, Ilona Juraskova2.   

Abstract

OBJECTIVE: Family caregivers can, at times, add complexity to clinical encounters. Difficult family caregivers and dynamics may: derail consultation communication, reduce patient autonomy, and compromise effective clinical care. A paucity of practical strategies guiding effective clinician-family communication exists. This study aimed to develop and evaluate the first comprehensive, evidence-based guidelines (the TRIO guidelines) for oncology physicians and nurses to better manage several complex/challenging situations involving family members.
METHODS: TRIO Guidelines were based on a comprehensive review of literature, relevant guidelines, and feedback from an expert advisory group (n = 10). Draft guidelines underwent two rounds of evaluation via an online Delphi consensus process involving international experts (n = 35).
RESULTS: Guidelines incorporate topic areas, strategies, and sub-strategies on managing challenging family involvement (7 topics). Example wording, behaviours and level of evidence are provided.
CONCLUSION: Challenging triadic interactions require skillful navigation, and the TRIO Guidelines provide clear, specific, and evidence-based strategies for clinicians to utilise in these potentially stressful encounters. Training based on these guidelines may improve both patient care and clinician confidence. PRACTICE IMPLICATIONS: Implementation of these guidelines into medical/nursing curricula and as a component of continuing professional development programs will likely be highly beneficial.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Communication strategies; Delphi consensus process; Family caregivers; Guidelines; Oncology health professionals

Mesh:

Year:  2018        PMID: 29526388     DOI: 10.1016/j.pec.2018.01.020

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  7 in total

1.  Caring for the informal cancer caregiver.

Authors:  Virginia Sun; Dan J Raz; Jae Y Kim
Journal:  Curr Opin Support Palliat Care       Date:  2019-09       Impact factor: 2.302

2.  "We need to bring them out from the shadows:" A qualitative study of safety net physician leaders' perspectives on caregivers.

Authors:  Wagahta Semere; Anupama G Cemballi; Dean Schillinger; Alejandra Casillas; Miya Lemberg; Courtney R Lyles
Journal:  Patient Educ Couns       Date:  2021-10-23

3.  Provider perspectives on integrating family caregivers into patient care encounters.

Authors:  Joan M Griffin; Catherine Riffin; Lauren R Bangerter; Karen Schaepe; Rachel D Havyer
Journal:  Health Serv Res       Date:  2022-01-26       Impact factor: 3.734

4.  Shared decision-making about cardiovascular disease medication in older people: a qualitative study of patient experiences in general practice.

Authors:  Jesse Jansen; Shannon McKinn; Carissa Bonner; Danielle Marie Muscat; Jenny Doust; Kirsten McCaffery
Journal:  BMJ Open       Date:  2019-03-20       Impact factor: 2.692

5.  Some Unresolved Ethical Challenges in Healthcare Decision-Making: Navigating Family Involvement.

Authors:  Sumytra Menon; Vikki A Entwistle; Alastair V Campbell; Johannes J M van Delden
Journal:  Asian Bioeth Rev       Date:  2020-03-05

6.  Involvement of adult children in treatment decision-making for older patients with cancer - a qualitative study of perceptions and experiences of oncology surgeons and nurses.

Authors:  Bea L Dijkman; Wolter Paans; Hanneke Van der Wal-Huisman; Barbara L van Leeuwen; Marie Louise Luttik
Journal:  Support Care Cancer       Date:  2022-09-01       Impact factor: 3.359

7.  Preparing for partnerships in cancer care: an explorative analysis of the role of family-based caregivers.

Authors:  Reema Harrison; Madhav Raman; Ramesh Lahiru Walpola; Ashfaq Chauhan; Ursula M Sansom-Daly
Journal:  BMC Health Serv Res       Date:  2021-06-29       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.